SCHEMBL633934

SCHEMBL633934

CCCCNC(CC)C(=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.48
SLC6A3 Q01959 5/20 0.48
SLC6A2 P23975 3/20 0.48
TSHR P16473 2/20 0.47
HPGD P15428 3/20 0.43
CCKBR P32239 2/20 0.43
POLB P06746 1/20 0.42
HTT P42858 1/20 0.42
GRN P28799 1/20 0.42
SORT1 Q99523 1/20 0.42
LMNA P02545 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
HIF1A Q16665 1/20 0.42
ALDH1A1 P00352 1/20 0.42
SLCO1B3 Q9NPD5 1/20 0.42
SLCO1B1 Q9Y6L6 1/20 0.42
MAPT P10636 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL634229 0.77 SLC6A3 (0.52) SLC6A4SLC6A3SLC6A2TSHRHPGD
SCHEMBL31061196 0.72 SLC6A4 (0.52) SLC6A4SLC6A3SLC6A2TSHRHPGD
SCHEMBL769423 0.72 SLC6A4 (0.52) SLC6A4SLC6A3SLC6A2TSHRHPGD
SCHEMBL21496986 0.71 TAS1R3 (0.45) SLC6A4SLC6A3SLC6A2TSHRHPGD
SCHEMBL634228 0.71 SLC6A4 (0.56) SLC6A4SLC6A3SLC6A2TSHRHPGD
SCHEMBL2291278 0.71 SLC6A4 (0.56) SLC6A4SLC6A3SLC6A2TSHRHPGD
SCHEMBL5276135 0.69 SLC6A4 (0.49) SLC6A4SLC6A3SLC6A2TSHRHPGD
SCHEMBL30471204 0.69 HPGD (0.53) SLC6A4SLC6A3SLC6A2TSHRHPGD
SCHEMBL29018410 0.69 HPGD (0.53) SLC6A4SLC6A3SLC6A2TSHRHPGD
SCHEMBL634330 0.69 HSD17B3 (0.58) TSHRHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419400-A1 MONOAMINE REUPTAKE INHIBITORS RESEARCH TRIANGLE INSTITUTE (US) 2012-02-22 EP disclosed
WO-2010121022-A1 MONOAMINE REUPTAKE INHIBITORS RESEARCH TRIANGLE INSTITUTE (US) 2010-10-21 WO disclosed